BLI Banque de Luxembourg Investments cut its position in Danaher Corporation (NYSE:DHR – Free Report) by 11.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 90,290 shares of the conglomerate’s stock after selling 11,740 shares during the quarter. BLI Banque de Luxembourg Investments’ holdings in Danaher were worth $20,830,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Enterprise Financial Services Corp grew its stake in Danaher by 1.4% during the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock valued at $737,000 after acquiring an additional 46 shares in the last quarter. Kennebec Savings Bank grew its stake in Danaher by 1.4% during the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after acquiring an additional 46 shares in the last quarter. Revolve Wealth Partners LLC grew its stake in Danaher by 2.6% during the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after acquiring an additional 47 shares in the last quarter. High Note Wealth LLC grew its stake in Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after acquiring an additional 47 shares in the last quarter. Finally, First Command Advisory Services Inc. grew its stake in Danaher by 4.4% during the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after acquiring an additional 47 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.
Danaher Trading Down 0.5%
NYSE:DHR opened at $183.47 on Tuesday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The firm has a market cap of $129.85 billion, a P/E ratio of 35.49, a P/E/G ratio of 2.46 and a beta of 0.81. The firm has a 50-day simple moving average of $181.19 and a 200-day simple moving average of $205.80.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is 30.95%.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on DHR shares. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. The Goldman Sachs Group dropped their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. Citigroup started coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. Argus dropped their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Finally, Royal Bank Of Canada started coverage on shares of Danaher in a research note on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $235.14.
View Our Latest Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
